{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Valhondo I"],"funding":["Instituto de Salud Carlos III","Ministerio de Ciencia e Innovación, Spain","Consejería de Educación, Ciencia y Formación Profesional, Junta de Extremadura, Spain","Regional Ministry of Economic Transformation, Industry, Knowledge, and Universities of the Junta de Andalucía","Secretaría General de Investigación, Desarrollo e Innovación en Salud, Junta de Andalucía, Spain"],"pagination":["325"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12500513"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["74(11)"],"pubmed_abstract":["Acute myeloid leukemia (AML) is the most common type of leukemia in adults. Despite advances in treatment, the average survival rate after diagnosis is low. AML also alters the patient's immune response further contributing to disease progression. The aim of this study was to analyze the expression of LAG-3, TIM-3 and PD-1 inhibitory checkpoints on NK cells and T cells from newly diagnosed AML patients and its impact in patient survival. NK cells and T cells from AML patients showed a lower expression of TIM-3 compared with healthy donors, whereas no significant differences were observed in the expression of LAG-3. The percentages of cells co-expressing these receptors showed a decrease in the percentage of LAG-3 + TIM-3 + PD-1 - NK and T cells from AML patients in comparison with healthy "],"journal":["Cancer immunology, immunotherapy : CII"],"pubmed_title":["Expression of the inhibitory checkpoints LAG-3, TIM-3, and PD-1 in NK cells and T cells in acute myeloid leukemia: preserved expression of LAG-3 is associated with patient survival."],"pmcid":["PMC12500513"],"funding_grant_id":["PI19/00075","SAF2017-87538-R","PECART 0060-2020","GR21178 and IB20132","DOC_01421","PI21/01125"],"pubmed_authors":["Lopez-Sejas N","Pera A","Martin C","Casas-Aviles I","Sanchez-Garcia J","Duran E","Valhondo I","Alonso C","Alvarez-Heredia P","Arcos MJ","Serrano J","Hassouneh F","Solana R","Bergua JM","Tarazona R"],"additional_accession":[]},"is_claimable":false,"name":"Expression of the inhibitory checkpoints LAG-3, TIM-3, and PD-1 in NK cells and T cells in acute myeloid leukemia: preserved expression of LAG-3 is associated with patient survival.","description":"Acute myeloid leukemia (AML) is the most common type of leukemia in adults. Despite advances in treatment, the average survival rate after diagnosis is low. AML also alters the patient's immune response further contributing to disease progression. The aim of this study was to analyze the expression of LAG-3, TIM-3 and PD-1 inhibitory checkpoints on NK cells and T cells from newly diagnosed AML patients and its impact in patient survival. NK cells and T cells from AML patients showed a lower expression of TIM-3 compared with healthy donors, whereas no significant differences were observed in the expression of LAG-3. The percentages of cells co-expressing these receptors showed a decrease in the percentage of LAG-3 + TIM-3 + PD-1 - NK and T cells from AML patients in comparison with healthy ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Oct","modification":"2026-06-05T12:46:06.684Z","creation":"2026-05-17T03:07:47.799Z"},"accession":"S-EPMC12500513","cross_references":{"pubmed":["41051510"],"doi":["10.1007/s00262-025-04169-y"]}}